ネフローゼ症候群の世界市場レポート 2025年

ネフローゼ症候群市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.7％で14億4,000万米ドルに成長します。予測期間中の成長は、ネフローゼ症候群に対する認知度の向上、慢性腎臓病（CKD）の有病率の上昇、代謝性疾患の発生率の増加、人口の高齢化、自己免疫疾患の発生率の上昇に起因すると考えられます。予測期間における主な動向としては、遠隔医療や遠隔モニタリングの拡大、ドラッグデリバリーシステムの進歩、治療方法の革新、バイオテクノロジーの進歩、デジタルヘルス技術の統合などが挙げられます。

腎臓疾患の有病率の上昇は、ネフローゼ症候群市場の成長を促進すると予想されます。腎臓病には、血液から老廃物や余分な水分を濾過する腎臓の能力を損なうさまざまな疾患が含まれます。腎臓病の発生率増加の要因としては、糖尿病、高血圧、肥満、高齢化、ナトリウムの大量摂取や水分補給不足などのライフスタイルの変化などが挙げられます。ネフローゼ症候群は糸球体を損傷し、ろ過やタンパク質の保持を損なうことによって腎臓病を悪化させる。例えば、2024年6月、オーストラリアの政府機関であるオーストラリア保健福祉研究所は、同国における慢性腎臓病（CKD）の死亡率が2021年の4.2％から2022年には6.2％に増加したと報告しました。その結果、腎臓病の有病率の増加がネフローゼ症候群市場の拡大に拍車をかけています。

ネフローゼ症候群市場の主要企業は、ネフローゼ症候群患者の体液管理を強化し浮腫を軽減するために、ループ利尿注射薬などの革新的な製剤の開発を優先しています。ループ利尿薬注射液は、ヘンレループにおけるナトリウムと塩化物の再吸収を阻害し、迅速な尿産生を促進する注射薬です。急性肺水腫、心不全、重症高血圧症など、体液の過負荷を軽減する治療によく使用されます。例えば、2024年3月、米国の製薬会社Avenacy Inc.は、ラシックスのジェネリック医薬品である注射用フロセミドを米国で発売し、心不全、肝硬変、腎疾患に関連する浮腫の治療薬として食品医薬品局から承認を取得しました。100mg/10mLを25回分ずつ包装した本剤の発売は、注射薬のポートフォリオを拡大するアベナシーの広範な戦略の一環であり、2024年には20製品以上を導入する計画です。本剤は、うっ血性心不全、肝硬変、腎疾患に伴う浮腫を有する成人および小児患者を適応症とし、ネフローゼ症候群.

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ネフローゼ症候群 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のネフローゼ症候群市場：成長率分析
• 世界のネフローゼ症候群市場の実績：規模と成長, 2019-2024
• 世界のネフローゼ症候群市場の予測：規模と成長, 2024-2029, 2034F
• 世界ネフローゼ症候群総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のネフローゼ症候群市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物
• デバイス
• 世界のネフローゼ症候群市場診断検査による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 尿検査
• 糸球体濾過率（GFR）
• 血液検査
• 腎生検
• コンピュータ断層撮影（CT）スキャン
• 世界のネフローゼ症候群市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリニック
• 病院
• 専門センター
• その他の用途
• 世界のネフローゼ症候群市場、薬物の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ステロイド
• 免疫抑制剤
• 利尿剤
• ACE阻害薬またはARB
• その他の薬物
• 世界のネフローゼ症候群市場、デバイスの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 透析装置
• 腹膜透析カテーテル
• 血液透析カテーテル
• 腎臓代替療法装置

第7章 地域別・国別分析

• 世界のネフローゼ症候群市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のネフローゼ症候群市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ネフローゼ症候群市場：競合情勢
• ネフローゼ症候群市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• GlaxoSmithKline plc
• Amgen Inc.
• Eli Lilly and Company
• Asahi Kasei Corporation
• Otsuka Pharmaceutical Co. Ltd.
• Astellas Pharma Inc.
• Vertex Pharmaceuticals
• Chugai Pharmaceutical Co. Ltd.
• Mallinckrodt Company
• Evotec SE
• Travere Therapeutics Inc.
• Aurinia Pharmaceuticals Inc.
• Orbis Biosciences Inc.
• Alpine Immune Sciences

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ネフローゼ症候群市場2029：新たな機会を提供する国
• ネフローゼ症候群市場2029：新たな機会を提供するセグメント
• ネフローゼ症候群市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Nephrotic syndrome is a kidney disorder characterized by excessive protein loss in the urine (proteinuria), low blood protein levels (hypoalbuminemia), high cholesterol levels (hyperlipidemia), and swelling (edema), particularly in the legs, feet, and around the eyes. It results from damage to the glomeruli, the kidney's filtering units, allowing protein to leak into the urine.

The primary types of nephrotic syndrome treatment include drugs and devices. Drugs are substances used to diagnose, treat, or prevent diseases by modifying bodily functions. Diagnosis of nephrotic syndrome involves various tests, such as urinalysis, glomerular filtration rate (GFR) measurement, blood tests, kidney biopsy, and computerized tomography (CT) scans. The key applications span clinics, hospitals, specialty centers, and other healthcare facilities.

The nephrotic syndrome market research report is one of a series of new reports from The Business Research Company that provides nephrotic syndrome market statistics, including the nephrotic syndrome industry global market size, regional shares, competitors with the nephrotic syndrome market share, detailed nephrotic syndrome market segments, market trends, and opportunities, and any further data you may need to thrive in the nephrotic syndrome industry. This nephrotic syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nephrotic syndrome market size has grown rapidly in recent years. It will grow from $0.87 billion in 2024 to $00.96 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth during the historic period can be attributed to the rising incidence of nephrotic syndrome, an increase in genetic disorders, growing obesity rates, the expanded use of immunosuppressive medications, and the increasing impact of genetic factors.

The nephrotic syndrome market size is expected to see rapid growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth during the forecast period can be attributed to increasing awareness of nephrotic syndrome, a rising prevalence of chronic kidney disease (CKD), a growing incidence of metabolic disorders, an aging population, and a higher occurrence of autoimmune diseases. Key trends in the forecast period include the expansion of telemedicine and remote monitoring, advancements in drug delivery systems, innovations in treatment modalities, progress in biotechnology, and the integration of digital health technologies.

The rising prevalence of kidney diseases is expected to drive the growth of the nephrotic syndrome market. Kidney diseases encompass various conditions that impair the kidneys' ability to filter waste and excess fluids from the blood. Factors contributing to the increasing incidence of kidney diseases include diabetes, hypertension, obesity, aging populations, and lifestyle changes such as high sodium intake and inadequate hydration. Nephrotic syndrome exacerbates kidney diseases by damaging the glomeruli, impairing filtration and protein retention. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that the percentage of chronic kidney disease (CKD) mortality in the country increased from 4.2% in 2021 to 6.2% in 2022. As a result, the growing prevalence of kidney diseases is fueling the expansion of the nephrotic syndrome market.

Leading companies in the nephrotic syndrome market are prioritizing the development of innovative formulations, such as loop diuretic injections, to enhance fluid management and reduce edema in nephrotic syndrome patients. Loop diuretic injection is an injectable medication that blocks sodium and chloride reabsorption in the loop of Henle, promoting rapid urine production. It is commonly used to treat conditions such as acute pulmonary edema, heart failure, and severe hypertension by reducing fluid overload. For instance, in March 2024, Avenacy Inc., a US-based pharmaceutical company, launched furosemide for injection in the U.S., a generic equivalent to Lasix, which received approval from the Food and Drug Administration for treating edema related to heart failure, liver cirrhosis, and kidney diseases. Packaged in 25-unit packs of 100 mg/10 mL doses, this launch is part of Avenacy's broader strategy to expand its injectable medication portfolio, with plans to introduce more than 20 products in 2024. This drug is indicated for adult and pediatric patients with edema associated with congestive heart failure, liver cirrhosis, and renal disease, including nephrotic syndrome.

In August 2023, Novartis AG, a Switzerland-based pharmaceutical company, acquired Chinook Therapeutics for $3.5 billion. This acquisition aims to strengthen Novartis' renal portfolio by incorporating Chinook Therapeutics' late-stage assets, atrasentan and zigakibart, which are being developed for the treatment of Immunoglobulin A Nephropathy (IgAN). The acquisition aligns with Novartis' strategic focus on innovative medicines. Chinook Therapeutics, a US-based biopharmaceutical company, specializes in developing treatments for nephrotic syndrome.

Major players in the nephrotic syndrome market are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Eli Lilly and Company, Asahi Kasei Corporation, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals, Chugai Pharmaceutical Co. Ltd., Mallinckrodt Company, Evotec SE, Travere Therapeutics Inc., Aurinia Pharmaceuticals Inc., Orbis Biosciences Inc., Alpine Immune Sciences, Kezar Life Sciences, Zenyaku Kogyo Co. Ltd.

North America was the largest region in the nephrotic syndrome market in 2024. The regions covered in nephrotic syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nephrotic syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nephrotic syndrome market consists of revenues earned by entities by providing services such as diagnosis and testing services, pharmacological treatment services, dialysis services, and kidney transplant services. The market value includes the value of related goods sold by the service provider or included within the service offering. The nephrotic syndrome market also includes sales of diuretics, anticoagulants, immunosuppressants, ACE inhibitors and Arbs and corticosteroids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nephrotic Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nephrotic syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nephrotic syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nephrotic syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Drugs; Devices
• 2) By Diagnosis Tests: Urinalysis; Glomerular Filtration Rate (GFR); Blood Test; Kidney Biopsy; Computerized Tomography (CT) Scan
• 3) By Application: Clinics; Hospitals; Speciality Centres; Other Applications
• Subsegments:
• 1) By Drugs: Steroids; Immunosuppressants; Diuretics; ACE Inhibitors Or ARBs; Other Drugs
• 2) By Devices: Dialysis Machines; Peritoneal Dialysis Catheters; Hemodialysis Catheters; Kidney Replacement Therapy Devices
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Bristol-Myers Squibb Company; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nephrotic Syndrome Market Characteristics

3. Nephrotic Syndrome Market Trends And Strategies

4. Nephrotic Syndrome Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Nephrotic Syndrome Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nephrotic Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nephrotic Syndrome Market Growth Rate Analysis
• 5.4. Global Nephrotic Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nephrotic Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nephrotic Syndrome Total Addressable Market (TAM)

6. Nephrotic Syndrome Market Segmentation

• 6.1. Global Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drugs
• Devices
• 6.2. Global Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Urinalysis
• Glomerular Filtration Rate (GFR)
• Blood Test
• Kidney Biopsy
• Computerized Tomography (CT) Scan
• 6.3. Global Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinics
• Hospitals
• Speciality Centres
• Other Applications
• 6.4. Global Nephrotic Syndrome Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Steroids
• Immunosuppressants
• Diuretics
• ACE Inhibitors Or ARBs
• Other Drugs
• 6.5. Global Nephrotic Syndrome Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dialysis Machines
• Peritoneal Dialysis Catheters
• Hemodialysis Catheters
• Kidney Replacement Therapy Devices

7. Nephrotic Syndrome Market Regional And Country Analysis

• 7.1. Global Nephrotic Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nephrotic Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nephrotic Syndrome Market

• 8.1. Asia-Pacific Nephrotic Syndrome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nephrotic Syndrome Market

• 9.1. China Nephrotic Syndrome Market Overview
• 9.2. China Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nephrotic Syndrome Market

• 10.1. India Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nephrotic Syndrome Market

• 11.1. Japan Nephrotic Syndrome Market Overview
• 11.2. Japan Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nephrotic Syndrome Market

• 12.1. Australia Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nephrotic Syndrome Market

• 13.1. Indonesia Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nephrotic Syndrome Market

• 14.1. South Korea Nephrotic Syndrome Market Overview
• 14.2. South Korea Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nephrotic Syndrome Market

• 15.1. Western Europe Nephrotic Syndrome Market Overview
• 15.2. Western Europe Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nephrotic Syndrome Market

• 16.1. UK Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nephrotic Syndrome Market

• 17.1. Germany Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nephrotic Syndrome Market

• 18.1. France Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nephrotic Syndrome Market

• 19.1. Italy Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nephrotic Syndrome Market

• 20.1. Spain Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nephrotic Syndrome Market

• 21.1. Eastern Europe Nephrotic Syndrome Market Overview
• 21.2. Eastern Europe Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nephrotic Syndrome Market

• 22.1. Russia Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nephrotic Syndrome Market

• 23.1. North America Nephrotic Syndrome Market Overview
• 23.2. North America Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nephrotic Syndrome Market

• 24.1. USA Nephrotic Syndrome Market Overview
• 24.2. USA Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nephrotic Syndrome Market

• 25.1. Canada Nephrotic Syndrome Market Overview
• 25.2. Canada Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nephrotic Syndrome Market

• 26.1. South America Nephrotic Syndrome Market Overview
• 26.2. South America Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nephrotic Syndrome Market

• 27.1. Brazil Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nephrotic Syndrome Market

• 28.1. Middle East Nephrotic Syndrome Market Overview
• 28.2. Middle East Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nephrotic Syndrome Market

• 29.1. Africa Nephrotic Syndrome Market Overview
• 29.2. Africa Nephrotic Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nephrotic Syndrome Market, Segmentation By Diagnosis Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nephrotic Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nephrotic Syndrome Market Competitive Landscape And Company Profiles

• 30.1. Nephrotic Syndrome Market Competitive Landscape
• 30.2. Nephrotic Syndrome Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Nephrotic Syndrome Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. GlaxoSmithKline plc
• 31.3. Amgen Inc.
• 31.4. Eli Lilly and Company
• 31.5. Asahi Kasei Corporation
• 31.6. Otsuka Pharmaceutical Co. Ltd.
• 31.7. Astellas Pharma Inc.
• 31.8. Vertex Pharmaceuticals
• 31.9. Chugai Pharmaceutical Co. Ltd.
• 31.10. Mallinckrodt Company
• 31.11. Evotec SE
• 31.12. Travere Therapeutics Inc.
• 31.13. Aurinia Pharmaceuticals Inc.
• 31.14. Orbis Biosciences Inc.
• 31.15. Alpine Immune Sciences

32. Global Nephrotic Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nephrotic Syndrome Market

34. Recent Developments In The Nephrotic Syndrome Market

35. Nephrotic Syndrome Market High Potential Countries, Segments and Strategies

• 35.1 Nephrotic Syndrome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nephrotic Syndrome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nephrotic Syndrome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer